ATAngela M. Thornton

Angela M. Thornton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Angela M. Thornton has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Ciriaco A Piccirillo

    Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD 20892

    1 shared publication
  • Ciriaco A. Piccirillo

    Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA

    1 shared publication
  • Donovan Ee

    1 shared publication
  • Erin E Donovan

    Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD 20892

    1 shared publication
  • Ethan M Shevach

    Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD 20892

    1 shared publication
  • Ethan M. Shevach

    Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA

    1 shared publication

Latest Publications

  • Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2

    by M. Thornton Angela

    IL-2 was originally identified as a growth factor critical for T cell proliferation in vitro. Although the early studies of IL-2 strongly implied an obligate role of IL-2 in T cell growth, it was later shown that mice deficient in IL-2 or in IL-2R developed an unexpected lymphocytic hyperproliferation and subsequent autoimmune disease. In separate studies of autoimmunity, it was observed that a population of CD4+ T cells suppressed the induction of autoimmunity in several in vivo models of autoimmune disease. It was not until the characterization of this subpopulation of CD4+ T cells demonstrated that they co-expressed the IL-2R-alpha chain (CD25) that the puzzling phenotype observed in IL-2 deficient mice began to be truly explained. The constitutive expression of the IL-2R-alpha chain on CD4+CD25+ T cells led to the obvious speculation that IL-2 signaling in CD4+CD25+ T cells was important to these cells. Recent studies have examined the role of IL-2 in the generation, the expansion, the survival and the effector function of CD4+CD25+ T cells. It is now evident that IL-2 is critical for the development of CD4+CD25+ T cells and the phenotype observed in IL-2 and IL-2R deficient mice is most readily explained by the absence of these potent suppressors.


  • T regulatory cells

    by Angela M. Thornton


  • Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function

    by Angela M Thornton, Erin E Donovan, Ciriaco A Piccirillo, Ethan M Shevach, Donovan Ee

    CD4+CD25+ T cells are potent immunoregulatory cells that suppress TCR-induced proliferation of CD4 and CD8 T cells in vitro by a cell contact-dependent mechanism. Addition of IL-2 or anti-CD28 abrogates CD4+CD25+-mediated suppression of proliferation and has been assumed to “break suppression.” We examined IL-2 mRNA by quantitative PCR in cocultures of mouse CD4+CD25+ and CD4+CD25− T cells. Although IL-2 gene transcription was inhibited in the presence or absence of exogenous IL-2, the addition of anti-CD28 stimulated endogenous IL-2 production. Surprisingly, transcription of IL-2 mRNA was also restored in the cocultures in the presence of anti-IL-2. These results are most compatible with a model in which CD4+CD25+ T cells do not suppress the initial activation of CD4+CD25− T cells, but mediate their suppressive effects following production of IL-2 by the responder cells resulting in both the expansion of the CD4+CD25+ T cells and the induction of their suppressor function.


  • Open Access

    Activation requirements for the induction of CD4+CD25+ T cell suppressor function

    by Angela M. Thornton, Ciriaco A. Piccirillo, Ethan M. Shevach

    The in vivo differentiation/survival of CD4+CD25+ T suppressor cells is dependent on IL‐2 and CD28‐mediated costimulatory signals. To determine the cytokine and costimulatory requirements for CD25+ T cells in vitro, we established a two‐stage culture system where CD25+ T cells were activated in a primary culture. In the subsequent culture, activated CD4+CD25+ cells were then mixed with responders in order to assess their suppressor function. Pre‐culture of CD25+ T cells with anti‐CD3 alone resulted in poor survival and minimal induction of suppressor activity. Pre‐culture in the presence of anti‐CD3 and IL‐2 or IL‐4, but not IL‐6, IL‐7, IL‐9, IL‐10 or IL‐15, resulted in proliferation of the CD25+ cells and induction of potent suppressor function. Inhibition of the interaction of CD28 or cytotoxic T lymphocyte‐associated antigen‐4 (CTLA‐4) with CD80/CD86 in the pre‐culture of CD4+CD25+ cells did not prevent the induction of suppressor function. Furthermore, the inhibition of costimulatory signals did not inhibit the ability of fresh CD25+ T cells to inhibit CD8+ responders under conditions where activation of the responders was independent of CD80/CD86. These studies support the view that activation of CD25+ T cells requires IL‐2/IL‐4 for their survival/differentiation into effector cells, but is independent of CD28/CTLA‐4‐mediated costimulation.